FindTrial
Sign In

Clinical study for oviduct ozone therapy in tubal secondary infertility: a randomized controlled trial

Clinical study for oviduct ozone therapy in tubal secondary infertility: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023669
Enrollment
Unknown
Registered
2019-06-06
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tubal secondary infertility

Interventions

experimental group:Interventional recanalization combined with ozone recanalization
control group:Interventional fallopian tube recanalization

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Childbearing age women aged 20-39 years; 2. Fallopian tube adhesion, obstruction and hydrosalpinx.

Exclusion criteria

Exclusion criteria: 1. Excessive length of fallopian tube or abnormal development; 2. Pelvic tuberculosis; 3. Ovarian-derived infertility; 4. Central systemic infertility.

Design outcomes

Primary

MeasureTime frame
Fallopian tube recanalization rate;Intrauterine pregnancy rate;—

Secondary

MeasureTime frame
Ectopic pregnancy rate;—

Countries

China

Contacts

Public ContactZhao Hu

Chengdu Women's and Children's Central Hospital

zhaohu1976@163.com+86 13881969153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026